134 related articles for article (PubMed ID: 6336658)
1. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.
Natali PG; Giacomini P; Bigotti A; Imai K; Nicotra MR; Ng AK; Ferrone S
Cancer Res; 1983 Feb; 43(2):660-8. PubMed ID: 6336658
[TBL] [Abstract][Full Text] [Related]
2. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
Nuti M; Castagna M; Squartini F
Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
4. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
Tupitsyn NN; Kadagidze ZG; Blokhina NG; Baryshnikov AIu; Ermilova VD; Artamonova EV; Moldenhauer G; Bernard A
Eksp Onkol; 1990; 12(2):54-8. PubMed ID: 1690634
[TBL] [Abstract][Full Text] [Related]
5. Expression of normal and tumor-associated antigens in human breast carcinoma.
Sawtell NM; DiPersio L; Michael JG; Pesce AJ; Weiss MA
Lab Invest; 1984 Aug; 51(2):225-32. PubMed ID: 6087025
[TBL] [Abstract][Full Text] [Related]
6. Lack of expression of HLA-ABC antigens in choriocarcinoma and other human tumor cell lines.
Travers PJ; Arklie JL; Trowsdale J; Patillo RA; Bodmer WF
Natl Cancer Inst Monogr; 1982; 60():175-80. PubMed ID: 6181407
[TBL] [Abstract][Full Text] [Related]
7. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
[TBL] [Abstract][Full Text] [Related]
8. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
Bhan AK; DesMarais CL
J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
[TBL] [Abstract][Full Text] [Related]
9. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
11. Variability in surface antigen expression of human breast epithelial cells cultured from normal breast, normal tissue peripheral to breast carcinomas, and breast carcinomas.
Ceriani RL; Peterson JA; Blank EW
Cancer Res; 1984 Jul; 44(7):3033-9. PubMed ID: 6144385
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.
Möller P; Mattfeldt T; Gross C; Schlosshauer P; Koch A; Koretz K; Moldenhauer G; Kaufmann M; Otto HF
Am J Pathol; 1989 Jul; 135(1):73-83. PubMed ID: 2549795
[TBL] [Abstract][Full Text] [Related]
13. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
15. Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin.
Natali PG; Bigotti A; Nicotra MR; Viora M; Manfredi D; Ferrone S
Cancer Res; 1984 Oct; 44(10):4679-87. PubMed ID: 6590117
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast.
Zuk JA; Walker RA
J Pathol; 1987 Aug; 152(4):275-85. PubMed ID: 3312546
[TBL] [Abstract][Full Text] [Related]
17. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions.
Natali PG; Cavaliere R; Bigotti A; Nicotra MR; Russo C; Ng AK; Giacomini P; Ferrone S
J Immunol; 1983 Mar; 130(3):1462-6. PubMed ID: 6600484
[TBL] [Abstract][Full Text] [Related]
18. Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.
Kufe DW; Nadler L; Sargent L; Shapiro H; Hand P; Austin F; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):851-7. PubMed ID: 6336659
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
20. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]